SCHEMBL21393051

SCHEMBL21393051

CC(C)c1ccccc1CN(C(=O)CCl)c1ccc2c(c1)OCCO2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
JAK2 O60674 2/20 0.55
HTT P42858 2/20 0.55
MAPT P10636 2/20 0.55
LMNA P02545 1/20 0.55
GPX4 P36969 2/20 0.55
PAX8 Q06710 2/20 0.55
FNIP1 Q8TF40 1/20 0.54
FEM1B Q9UK73 1/20 0.54
TSHR P16473 6/20 0.41
POLB P06746 3/20 0.41
PTGDR2 Q9Y5Y4 2/20 0.41
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21393049 0.94 KMT2A (0.61) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21401891 0.85 RAB9A (0.58) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21401721 0.81 KMT2A (0.66) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL20456266 0.80 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21392985 0.80 MEN1 (0.64) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21392822 0.78 KMT2A (0.66) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21393094 0.78 KMT2A (0.70) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21401863 0.78 KMT2A (0.62) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21392987 0.77 KMT2A (0.61) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL21401880 0.77 KMT2A (0.61) ALDH1A1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
WO-2019183600-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-09-26 WO disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 ALDH1A1 4188/4885NPC1 37/4885RAB9A 223/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 ALDH1A1 4188/4885NPC1 37/4885RAB9A 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.